{
    "2019-07-07": [
        [
            {
                "time": "2019-07-03",
                "original_text": "医药生物全球视野–西南证券海外医药一周资讯（2019.7.1-2019.7.5）【西南医药朱国广陈铁林团队】",
                "features": {
                    "keywords": [
                        "医药生物",
                        "全球视野",
                        "西南证券",
                        "海外医药",
                        "一周资讯"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-03",
                "original_text": "IPO扩容潮 避险资金或转向漂亮50",
                "features": {
                    "keywords": [
                        "IPO扩容",
                        "避险资金",
                        "漂亮50"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "大盘蓝筹"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}